Edition:
United Kingdom

Evofem Biosciences Inc (EVFM.OQ)

EVFM.OQ on NASDAQ Stock Exchange Capital Market

7.27USD
20 Feb 2018
Change (% chg)

-- (--)
Prev Close
$7.27
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
40,132
52-wk High
$15.60
52-wk Low
$1.80

Chart for

About

Evofem Biosciences Inc, formerly Neothetics, Inc., is a clinical-stage specialty pharmaceutical company, which develops therapeutics. The Company focuses on localized fat reduction and body contouring. It focuses on the development of LIPO-202 for the reduction of central abdominal bulging due to subcutaneous fat in non-obese... (more)
No analyst recommendations are available for .

Overall

Beta: --
Market Cap(Mil.): $6.33
Shares Outstanding(Mil.): 13.83
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.10 16.60
EPS (TTM): -- -- --
ROI: -- 14.90 10.66
ROE: -- 16.41 14.30

BRIEF-Evofem Biosciences Receives Fast Track Designation For Amphora For Prevention Of Chlamydia

* EVOFEM BIOSCIENCES RECEIVES FAST TRACK DESIGNATION FOR AMPHORA FOR PREVENTION OF CHLAMYDIA

12:02pm GMT

Earnings vs. Estimates